Pharmaceutical company CSL Behring plans job cuts in Bern
Keystone-SDA
Australian pharmaceutical company CSL Behring is planning to cut jobs at its site in the city of Bern. The company confirmed a report in the Capital to the news agency Keystone-SDA.
+ Get the most important news from Switzerland in your inbox
This “further development” is necessary “in order to be successful in the long term and to secure our role as a reliable partner in the healthcare sector worldwide”, it said in response to an enquiry. “Various functions” are affected by the cutbacks.
+ What lies ahead for Switzerland? Economic outlook 2026
According to the Bern-based Tamedia publications, around 180 jobs will be cut in Wankdorf. CSL Behring would not comment on this figure, but states that it exceeds the threshold for a consultation procedure.
For companies with more than 300 employees, such as CSL, consultation is mandatory from 30 redundancies. According to its own information, the company employs around 1,800 staff in Bern.
Last August, the parent company CSL Limited announced a reduction in the workforce of up to 15% across all sites. It was also previously announced that the research and development department in Bern would be merged with a unit in Zurich.
More
More
Swiss economy grew slightly at tail end of 2025
Adapted from German by AI/mga
We select the most relevant news for an international audience and use automatic translation tools to translate them into English. A journalist then reviews the translation for clarity and accuracy before publication.
Providing you with automatically translated news gives us the time to write more in-depth articles. The news stories we select have been written and carefully fact-checked by an external editorial team from news agencies such as Bloomberg or Keystone.
If you have any questions about how we work, write to us at english@swissinfo.ch
